Published in Mol Psychiatry on October 25, 2011
Sleep Treatment Outcome Predictors: A Pilot Study (STOP-pilot) (STOP-Pilot) | NCT03062891
Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder. PLoS One (2013) 1.44
Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment. PLoS One (2016) 1.38
Serotonin transporter genotype 5HTTLPR as a marker of differential susceptibility? A meta-analysis of child and adolescent gene-by-environment studies. Transl Psychiatry (2012) 1.33
The neurobiological correlates of childhood adversity and implications for treatment. Acta Psychiatr Scand (2013) 1.01
Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biol Mood Anxiety Disord (2013) 1.01
Toward an integration of cognitive and genetic models of risk for depression. Cogn Emot (2012) 0.99
Epigenetic Modulation of Mood Disorders. J Genet Syndr Gene Ther (2013) 0.98
Therapygenetics: moving towards personalized psychotherapy treatment. Trends Cogn Sci (2011) 0.97
MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Mol Psychiatry (2013) 0.90
Neurotrophic gene polymorphisms and response to psychological therapy. Transl Psychiatry (2012) 0.90
Functional gene polymorphisms in the serotonin system and traumatic life events modulate the neural basis of fear acquisition and extinction. PLoS One (2012) 0.87
Therapygenetics: the 5HTTLPR as a biomarker for response to psychological therapy? Mol Psychiatry (2012) 0.87
Serotonin transporter [corrected] methylation and response to cognitive behaviour therapy in children with anxiety disorders. Transl Psychiatry (2014) 0.86
From observational to dynamic genetics. Front Genet (2014) 0.85
5HTT is associated with the phenotype psychological flexibility: results from a randomized clinical trial. Eur Arch Psychiatry Clin Neurosci (2015) 0.84
Non-replication of the association between 5HTTLPR and response to psychological therapy for child anxiety disorders. Br J Psychiatry (2015) 0.83
The interaction between stress and genetic factors in the etiopathogenesis of depression. World Psychiatry (2015) 0.82
Therapygenetics: anterior cingulate cortex-amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia. J Neural Transm (Vienna) (2014) 0.80
A Genome-Wide Test of the Differential Susceptibility Hypothesis Reveals a Genetic Predictor of Differential Response to Psychological Treatments for Child Anxiety Disorders. Psychother Psychosom (2016) 0.80
The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Front Pharmacol (2013) 0.80
HPA AXIS RELATED GENES AND RESPONSE TO PSYCHOLOGICAL THERAPIES: GENETICS AND EPIGENETICS. Depress Anxiety (2015) 0.79
5-HTTLPR, HTR1A, and HTR2A cumulative genetic score interacts with mood reactivity to predict mood-congruent gaze bias. Cogn Affect Behav Neurosci (2014) 0.79
'As above, so below' examining the interplay between emotion and the immune system. Immunology (2014) 0.79
Antidepressant treatment response is modulated by genetic and environmental factors and their interactions. Ann Gen Psychiatry (2014) 0.78
Genome-wide association study of response to cognitive-behavioural therapy in children with anxiety disorders. Br J Psychiatry (2016) 0.78
Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response. Genome Med (2012) 0.78
Stability and Change in Genetic and Environmental Influences on Well-Being in Response to an Intervention. PLoS One (2016) 0.77
Neurophysiological markers that predict and track treatment outcomes in childhood anxiety. J Abnorm Child Psychol (2013) 0.77
The stability and change of etiological influences on depression, anxiety symptoms and their co-occurrence across adolescence and young adulthood. Psychol Med (2015) 0.77
Genetics in child and adolescent psychiatry: methodological advances and conceptual issues. Eur Child Adolesc Psychiatry (2015) 0.76
5-HTTLPR moderates naltrexone and psychosocial treatment responses in heavy drinking men who have sex with men. Alcohol Clin Exp Res (2014) 0.76
Short alleles, bigger smiles? The effect of 5-HTTLPR on positive emotional expressions. Emotion (2015) 0.76
Advancing pediatric psychiatry research: linking neurobiological processes to novel treatment and diagnosis through Research Domain Criteria (RDoC). Ther Innov Regul Sci (2015) 0.76
An integrative review of attention biases and their contribution to treatment for anxiety disorders. Front Psychol (2015) 0.75
Aetiological influences on stability and change in emotional and behavioural problems across development: a systematic review. Psychopathol Rev (2016) 0.75
Association between serotonin cumulative genetic score and the Behavioral Approach System (BAS): Moderation by early life environment. Pers Individ Dif (2014) 0.75
Serotonin transporter polymorphism (5HTTLPR), severe childhood abuse and depressive symptom trajectories in adulthood. BJPsych Open (2015) 0.75
Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences? Transl Psychiatry (2014) 0.75
Differential sensitivity to the environment: contribution of cognitive biases and genes to psychological wellbeing. Mol Psychiatry (2016) 0.75
Adverse Prenatal, Perinatal and Neonatal Experiences in Children with Anxiety Disorders. Child Psychiatry Hum Dev (2016) 0.75
The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther (1995) 11.36
The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry (2011) 6.66
Vulnerability genes or plasticity genes? Mol Psychiatry (2009) 4.96
The implications of gene-environment interactions in depression: will cause inform cure? Mol Psychiatry (2008) 1.30
Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies. Mol Psychiatry (2009) 1.21
Pharmacogenetics of antidepressant response. Expert Rev Neurother (2011) 1.21
Serotonin-system polymorphisms (5-HTTLPR and -1438G/A) and responses of patients with bulimic syndromes to multimodal treatments. J Clin Psychiatry (2008) 1.05
The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry (1988) 12.83
Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet (2004) 7.33
A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry (1991) 6.74
The Genome Sequence DataBase: towards an integrated functional genomics resource. Nucleic Acids Res (1999) 6.20
The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia? Br J Psychiatry (1994) 4.40
The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev (1996) 4.10
Screening could seriously damage your health. BMJ (1997) 4.04
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
The chemistry and biology of unusual DNA structures adopted by oligopurine.oligopyrimidine sequences. FASEB J (1988) 3.84
The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry (2009) 3.59
Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature (1991) 3.43
ISYS: a decentralized, component-based approach to the integration of heterogeneous bioinformatics resources. Bioinformatics (2001) 3.36
Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature (1997) 3.27
Informal advice- and information-seeking between physicians. J Med Educ (1981) 3.23
Genomic mismatch scanning in pedigrees. IMA J Math Appl Med Biol (1994) 3.16
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Evaluation of a modified self-report measure of social adjustment. Br J Psychiatry (1982) 3.06
Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry (2010) 2.95
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science (1992) 2.89
Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet (1997) 2.83
A comparison of clinical and diagnostic interview schedule diagnoses. Physician reexamination of lay-interviewed cases in the general population. Arch Gen Psychiatry (1985) 2.66
Drug treatment for benign prostatic hyperplasia. BMJ (1997) 2.65
Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin Exp Immunol (1973) 2.55
Setting up consensus standards for the care of patients in general practice. Br J Gen Pract (1991) 2.49
Risk and severity of motor vehicle crashes in patients with obstructive sleep apnoea/hypopnoea. Thorax (2008) 2.42
Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol Psychiatry (2008) 2.38
Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37
A retrospective review of cervical cytology in women developing invasive squamous cell carcinoma. Br J Obstet Gynaecol (1983) 2.31
The management of acute bronchiolitis. Thoracic Society of Australia and New Zealand. J Paediatr Child Health (1993) 2.30
Family treatment of childhood anxiety: a controlled trial. J Consult Clin Psychol (1996) 2.29
Meta-analysis of genome searches. Ann Hum Genet (1999) 2.27
Effects of postnatal depression on infant development. Arch Dis Child (1997) 2.24
The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry (1999) 2.23
Thyroiditis in T cell-depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocyte serum. Clin Exp Immunol (1975) 2.22
Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol (1991) 2.20
Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol (2000) 2.20
Increased incidence of cervical cytological abnormalities in women with genital warts or contact with genital warts: a need for increased vigilance? Genitourin Med (1991) 2.19
Thyroiditis in T cell-depleted rats: suppression of the autoallergic response by reconstitution with normal lymphoid cells. Clin Exp Immunol (1976) 2.14
Genetic risk factors as possible causes of the variation in European suicide rates. Br J Psychiatry (2001) 2.11
Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study. Br J Dermatol (2013) 2.10
Genomics: the next psychiatric revolution? Br J Psychiatry (1996) 2.09
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Genetic influence on language delay in two-year-old children. Nat Neurosci (1998) 2.06
Retention of the tetragonal to orthorhombic structural transition in F-substituted SmFeAsO: a new phase diagram for SmFeAs(O(1-x)F(x)). Phys Rev Lett (2011) 2.03
Family enhancement of cognitive style in anxious and aggressive children. J Abnorm Child Psychol (1996) 2.02
A new venous prosthesis. Surgery (1972) 2.01
Regulation of nitrate reductase in the basidiomycete Ustilago maydis. J Bacteriol (1970) 2.00
Early history of lipoplasty in the United States. Aesthetic Plast Surg (1990) 1.96
Parent-child interactions and anxiety disorders: an observational study. Behav Res Ther (2001) 1.96
School feeding for improving the physical and psychosocial health of disadvantaged elementary school children. Cochrane Database Syst Rev (2007) 1.88
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88
Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care (2000) 1.84
Hysterectomy and psychiatric disorder: I. Levels of psychiatric morbidity before and after hysterectomy. Br J Psychiatry (1982) 1.83
Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry (2000) 1.81
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells. Leukemia (2012) 1.77
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics (1999) 1.76
Fractures of the spine in diffuse idiopathic skeletal hyperostosis. Clin Orthop Relat Res (1991) 1.76
The effect of family structure on linkage tests using allelic association. Am J Hum Genet (1998) 1.73
Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease. Aliment Pharmacol Ther (2009) 1.72
Co-occurrence of ADHD and low IQ has genetic origins. Am J Med Genet B Neuropsychiatr Genet (2004) 1.69
A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst (1994) 1.69
Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Genes Brain Behav (2006) 1.68
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev (2008) 1.65
DNA variation in a 5-Mb region of the X chromosome and estimates of sex-specific/type-specific mutation rates. Am J Hum Genet (1999) 1.64
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64
Supercoiling and integration host factor change the DNA conformation and alter the flow of convergent transcription in phage Mu. J Biol Chem (1989) 1.64
Mutation of Tec family kinases alters T helper cell differentiation. Nat Immunol (2001) 1.63
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry (2010) 1.63
Incidence of acquired demyelination of the CNS in Canadian children. Neurology (2009) 1.63
Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B. Am J Hum Genet (1999) 1.61
Purpura fulminans: recognition, diagnosis and management. Arch Dis Child (2011) 1.59
In response to 'variations in glucose self-monitoring during oral hypoglycaemic therapy in primary care'. Diabet Med (2005) 1.58
Reliability of DSM-III-R anxiety disorder categories. Using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Arch Gen Psychiatry (1993) 1.55
Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun (2006) 1.54
Flawed gun policy research could endanger public safety. Am J Public Health (1997) 1.53
The diagnostic interview for psychoses (DIP): development, reliability and applications. Psychol Med (2005) 1.48
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med (2011) 1.45
Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br J Psychiatry (2009) 1.45
Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry (2011) 1.44
A rapid micro-method for the phytohaemagglutinin-induced human lymphocyte transformation test. Clin Exp Immunol (1974) 1.44
The demise of the published case report--is resuscitation necessary? Br J Psychiatry (1999) 1.43
Neuro-ophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas. J Neurosurg (1990) 1.43
HTLV-1 infection and tropical spastic paraparesis in Esmeraldas Province of Ecuador. Trans R Soc Trop Med Hyg (1995) 1.42
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Trajectories of change in depression severity during treatment with antidepressants. Psychol Med (2009) 1.40
Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study. Br J Dermatol (2012) 1.39
The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air. Arch Gen Psychiatry (1989) 1.39
Lexical and grammatical development: a behavioural genetic perspective. J Child Lang (2000) 1.39
Psychotic depression presenting as status epilepticus. Br J Psychiatry (1990) 1.39
Bornagain? Neurotrophic viruses in neuropsychiatry. Mol Psychiatry (2000) 1.39
Massive lymphocytic infiltration of uterine leiomyomas associated with GnRH agonist treatment. Histopathology (1998) 1.38
Psychological considerations in lipoplasty: the problematic or "special care" patient. Ann Plast Surg (1989) 1.38
Development and validation of a measure of children's automatic thoughts: the children's automatic thoughts scale. Behav Res Ther (2002) 1.38
The management of acute laryngo-tracheo-bronchitis (croup): a consensus view. J Paediatr Child Health (1992) 1.38
Using interactive videos in general practice to inform patients about treatment choices: a pilot study. Fam Pract (1995) 1.37
The cognitive development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry (1996) 1.35
The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut (2002) 1.34
Sudden onset of pitting corrosion on stainless steel as a critical phenomenon. Science (2004) 1.33